These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 16041400)

  • 1. Comparison of the biological activities of anagrelide and its major metabolites in haematopoietic cell cultures.
    Wang G; Franklin R; Hong Y; Erusalimsky JD
    Br J Pharmacol; 2005 Oct; 146(3):324-32. PubMed ID: 16041400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison between anagrelide and hydroxycarbamide in their activities against haematopoietic progenitor cell growth and differentiation: selectivity of anagrelide for the megakaryocytic lineage.
    Hong Y; Wang G; Del Arroyo AG; Hernandez J; Skene C; Erusalimsky JD
    Leukemia; 2006 Jun; 20(6):1117-22. PubMed ID: 16557242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anagrelide represses GATA-1 and FOG-1 expression without interfering with thrombopoietin receptor signal transduction.
    Ahluwalia M; Donovan H; Singh N; Butcher L; Erusalimsky JD
    J Thromb Haemost; 2010 Oct; 8(10):2252-61. PubMed ID: 20586925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anagrelide platelet-lowering effect is due to inhibition of both megakaryocyte maturation and proplatelet formation: insight into potential mechanisms.
    Espasandin YR; Glembotsky AC; Grodzielski M; Lev PR; Goette NP; Molinas FC; Marta RF; Heller PG
    J Thromb Haemost; 2015 Apr; 13(4):631-42. PubMed ID: 25604267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A preliminary investigation into the action of anagrelide: thrombopoietin-c-Mpl receptor interactions.
    McCarty JM; Melone PD; Simanis JP; Kanamori D; Dessypris EN; Warshamana-Greene GS
    Exp Hematol; 2006 Jan; 34(1):87-96. PubMed ID: 16413395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of human primary megakaryocyte differentiation by anagrelide: a gene expression profiling analysis.
    Sakurai K; Fujiwara T; Hasegawa S; Okitsu Y; Fukuhara N; Onishi Y; Yamada-Fujiwara M; Ichinohasama R; Harigae H
    Int J Hematol; 2016 Aug; 104(2):190-9. PubMed ID: 27084257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of anagrelide on human megakaryocytopoiesis.
    Solberg LA; Tefferi A; Oles KJ; Tarach JS; Petitt RM; Forstrom LA; Silverstein MN
    Br J Haematol; 1997 Oct; 99(1):174-80. PubMed ID: 9359521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is the platelet lowering activity of anagrelide mediated by its major metabolite 2-amino-5,6-dichloro-3,4-dihydroquinazoline (RL603)?
    Erusalimsky JD; Hong Y; Franklin R
    Exp Hematol; 2002 Jul; 30(7):625-6; author reply 626-7. PubMed ID: 12135656
    [No Abstract]   [Full Text] [Related]  

  • 9. Analysis of the mechanism of anagrelide-induced thrombocytopenia in humans.
    Mazur EM; Rosmarin AG; Sohl PA; Newton JL; Narendran A
    Blood; 1992 Apr; 79(8):1931-7. PubMed ID: 1562721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
    Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ
    Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of anagrelide on in vivo megakaryocyte proliferation and maturation in essential thrombocythemia.
    Tomer A
    Blood; 2002 Mar; 99(5):1602-9. PubMed ID: 11861274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anagrelide metabolite induces thrombocytopenia in mice by inhibiting megakaryocyte maturation without inducing platelet aggregation.
    Lane WJ; Hattori K; Dias S; Peerschke EI; Moore MA; Blanset DL; Lang PC; Petrone M; Rafii S
    Exp Hematol; 2001 Dec; 29(12):1417-24. PubMed ID: 11750100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Essential thrombocythemia: therapy with anagrelide].
    Mazzucconi MG; Ferrari A; Balduini CL
    Haematologica; 1991 Jun; 76 Suppl 3():378-81. PubMed ID: 1661268
    [No Abstract]   [Full Text] [Related]  

  • 14. CD226 is expressed on the megakaryocytic lineage from hematopoietic stem cells/progenitor cells and involved in its polyploidization.
    Ma D; Sun Y; Lin D; Wang H; Dai B; Zhang X; Ouyang W; Jian J; Jia W; Xu X; Jin B
    Eur J Haematol; 2005 Mar; 74(3):228-40. PubMed ID: 15693793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expansion of megakaryocyte precursors and stem cells from umbilical cord blood CD34+ cells in collagen and liquid culture media.
    Shaw PH; Olszewski M; Kletzel M
    J Hematother Stem Cell Res; 2001 Jun; 10(3):391-403. PubMed ID: 11454314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human mesenchymal stem cells support megakaryocyte and pro-platelet formation from CD34(+) hematopoietic progenitor cells.
    Cheng L; Qasba P; Vanguri P; Thiede MA
    J Cell Physiol; 2000 Jul; 184(1):58-69. PubMed ID: 10825234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of recombinant human thrombopoietin alone and in combination with erythropoietin and early-acting cytokines on human mobilized purified CD34+ progenitor cells cultured in serum-depleted medium.
    Birkmann J; Oez S; Smetak M; Kaiser G; Kappauf H; Gallmeier WM
    Stem Cells; 1997; 15(1):18-32. PubMed ID: 9007219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anagrelide--new antiplatelet drug].
    Robak T; Treliński J; Hołub A
    Acta Haematol Pol; 1994; 25(4):309-15. PubMed ID: 7847031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flt3/Flk-2-ligand in synergy with thrombopoietin delays megakaryocyte development and increases the numbers of megakaryocyte progenitor cells in serum-free cultures initiated with CD34+ cells.
    Sigurjónsson OE; Gudmundsson KO; Haraldsdóttir V; Rafnar T; Gudmundsson S
    J Hematother Stem Cell Res; 2002 Apr; 11(2):389-400. PubMed ID: 11983110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effects of thrombopoietic-stimulatory factor and spleen cell-conditioned medium on megakaryocytopoiesis in a short-term bone marrow liquid culture system.
    Petursson SR; Chervenick PA
    Exp Hematol; 1988 Sep; 16(8):660-6. PubMed ID: 3261250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.